Rescue therapy with tacrolimus in simultaneous pancreas/kidney transplantation. 1997

G Becker, and O Witzke, and J Friedrich, and K H Albrecht, and K Wagner, and T Philipp, and U Heemann
Department of Nephrology, IG1-9, University Hospital Essen, Germany.

Tacrolimus has been effective both in primary and rescue therapy following steroid and OKT3-resistant acute rejection in liver and kidney transplantation. Due to the effects of tacrolimus on glucose metabolism, there has been concern about its use in simultaneous pancreas/kidney transplantation. We report on the results of six patients (three female, three male, age 35.2 +/- 7.3 years) converted from cyclosporin A to tacrolimus following simultaneous pancreas/kidney transplantation in steroid-resistant acute rejection. Tacrolimus was induced 2.8 +/- 1.7 months (range 1-4.8 months) after transplantation; follow-up was 3-18 months. Following conversion, creatinine levels declined in all patients [3.5 +/- 1.2 mg/dl before conversion, 3.0 +/- 1.9 mg/dl (n = 6) at three months, 1.4 +/- 0.1 mg/ dl at 1 year (n = 3)]. Before conversion, fasting blood glucose levels averaged 154 +/- 33 mg/dl, with three patients receiving insulin. Three months later no patient required insulin, the mean glucose level being 107 +/- 23 mg/dl (n = 6); at 1 year it was 92 +/- 9 mg/dl (n = 3). One patient lost his pancreatic graft after 4 months due to a mycotic aneurysm. We conclude that conversion to tacrolimus is a safe and effective treatment in cases of steroid-resistant rejections following pancreas/ kidney transplantation.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016035 Pancreas Transplantation The transference of a pancreas from one human or animal to another. Grafting, Pancreas,Transplantation, Pancreas,Graftings, Pancreas,Pancreas Grafting,Pancreas Graftings,Pancreas Transplantations,Transplantations, Pancreas
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

G Becker, and O Witzke, and J Friedrich, and K H Albrecht, and K Wagner, and T Philipp, and U Heemann
April 1995, Transplantation,
G Becker, and O Witzke, and J Friedrich, and K H Albrecht, and K Wagner, and T Philipp, and U Heemann
January 1997, Transplantation proceedings,
G Becker, and O Witzke, and J Friedrich, and K H Albrecht, and K Wagner, and T Philipp, and U Heemann
April 1996, Transplantation,
G Becker, and O Witzke, and J Friedrich, and K H Albrecht, and K Wagner, and T Philipp, and U Heemann
January 2024, Transplant international : official journal of the European Society for Organ Transplantation,
G Becker, and O Witzke, and J Friedrich, and K H Albrecht, and K Wagner, and T Philipp, and U Heemann
July 2014, Clinical transplantation,
G Becker, and O Witzke, and J Friedrich, and K H Albrecht, and K Wagner, and T Philipp, and U Heemann
June 1998, Transplantation proceedings,
G Becker, and O Witzke, and J Friedrich, and K H Albrecht, and K Wagner, and T Philipp, and U Heemann
January 1999, Medicina,
G Becker, and O Witzke, and J Friedrich, and K H Albrecht, and K Wagner, and T Philipp, and U Heemann
September 2007, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
G Becker, and O Witzke, and J Friedrich, and K H Albrecht, and K Wagner, and T Philipp, and U Heemann
October 1991, ANNA journal,
G Becker, and O Witzke, and J Friedrich, and K H Albrecht, and K Wagner, and T Philipp, and U Heemann
August 1991, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Copied contents to your clipboard!